Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Jenburkt Pharmaceuticals Ltd

NSE: JENBURPH · BSE: 524731 · Pharmaceuticals & Biotechnology · 16 announcements

Share price
₹892.10
Market cap
₹393.7 Cr
Revenue (annual)
₹168.7 Cr
Net profit (annual)
₹34.74 Cr
P/E (TTM)
12.0×Sector 47.4×
Promoter holding
46.62%-0.02% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

Time

2 announcements with these filters

13:20 IST BSE
Other Announcement

Jenburkt Pharmaceuticals Other Announcement

Jenburkt Pharmaceuticals clarified its shares are permitted to trade on NSE without a listing application. The shares remain listed on BSE under the Permitted to Trade category.

16:23 IST BSE
Management Change

Jenburkt Pharmaceuticals Management Change

Mr. Vinay Bhatt, Senior Vice President- International Business, has resigned from Jenburkt Pharmaceuticals Limited effective September 18, 2026, due to personal reasons.